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Summary We report here a case of pilsicainide intoxication presenting as left
ventricular dyssynchrony in a patient who had been treated on hemodialysis. ThisVentricular function; is the ﬁrst report that assessed cardiac function during pilsicainide intoxication by
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Introduction
Pilsicainide is a class Ic antiarrhythmic agent and
is largely excreted via the kidney [1]. Pilsicainide
intoxication has been reported in patients with
renal dysfunction [2,3]. We report here a case
of pilsicainide intoxication presenting as left ven-
tricular dyssynchrony in a patient who had been
treated on hemodialysis. This is the ﬁrst report that
assessed cardiac function during pilsicainide intox-
ication by left ventriculography and right heart
catheterization.Case report
A 65-year-old man was admitted to our hospital
because of chest pain on 26 March 2008. He had
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een diagnosed with diabetes mellitus and hyper-
ension at age 45 years. He had developed renal
ailure and had been treated with hemodialysis at
local hospital since he was 63 years old. He had
aken pilsicainide (50mg/day) for arrhythmia. On
6 March 2008, he suffered from chest pain and pal-
itation, and he was admitted to his local hospital.
e was diagnosed with acute myocardial infarc-
ion and transferred to our hospital. On admission,
is blood pressure was 89/37mmHg and pulse rate
as 100 bpm. His height was 160 cm and body
eight was 65 kg. Electrocardiogram showed ST
epression in I, II, aVF, V1∼ 6 leads with wide QRS
nd marked QT prolongation (Fig. 1). Chest X-ray
howed mild cardiomegaly (Fig. 2) Echocardiogram
howed severe left ventricular dysfunction in apex.
aboratory data indicated azotemia and hyper-
alemia (Table 1). Emergent coronary angiography
evealed no occlusion of epicardial artery. Left ven-
riculography showed dyssynchronous wall motion
delayed contraction in basal portion and apical
yskinesis) without mitral regurgitation (Fig. 3).
gy. Published by Elsevier Ireland Ltd. All rights reserved.
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ight heart catheterization showed decreased car-
2iac index (2.42 l/(minm )) and stroke volume
ndex (34.6ml/(beatm2)) and elevated mean pul-
onary artery wedge pressure (15mmHg). After
ardiac catheterization, it had been apparent that
Figure 2 Chest X-ray on admission.
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erum concentration of pilsicainide on admission
as 2.75g/ml (therapeutic level 0.2∼ 0.9g/ml).
hen, we diagnosed pilsicainide intoxication. Pil-
icainide was discontinued, and hemodialysis was
erformed. After hemodialysis, electrocardiogra-
hy showed Brugada-type pattern. Then QRS had
Table 1 Laboratory data on admission
White-cell count (per mm3) 12,400
Hemoglobin (g/dl) 15.9
Platelet count (per mm3) 14.6× 104
Creatinine (mg/dl) 13.0
Urea (mg/dl) 64
Sodium (mEq/l) 137
Potassium (mEq/l) 6.5
Chloride (mEq/l) 99
Albumin (g/dl) 3.9
Aspartate aminotransferase (IU/l) 14
Alanine aminotransferase (IU/l) 21
Lactate dehydrogenase (IU/l) 267
Creatine kinase (IU/l) 140
Glucose (mg/dl) 196
Brain natriuretic peptide (pg/ml) 219
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(Figure 3 Left ventriculography on admission. Basal po
portion showed dyskinetic motion. (A) End diastole, (B) e
gradually narrowed, and electrocardiographic ﬁnd-
ings had become normal (Fig. 4). Blood pressure
had gradually elevated and chest symptoms had
not recurred. Ventricular tachyarrhythmia had not
appeared and in-hospital course was uneventful.
Left ventriculography on 18 days from admission
showed normal left ventricular function. Right
heart catheterization showed improved cardiac
D
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Fig. 4 Serial changes onn contracted later than midventricular portion. Apical
systole, (C) late systole and (D) end systole.
ndex (3.00 l/(minm2)) and stroke volume index
45.1ml/(beatm2)).iscussion
ilsicainide is a pure sodium channel blocker with
low recovery kinetics [4]. This drug has been
electrocardiogram.
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Rilsicainide intoxication
hown to increase PQ interval, QRS width, and QTc,
nd prolongation of these variables was well cor-
elated with the plasma levels [2,5]. Pilsicainide
ntoxication has been known to cause ventricular
achycardia, sinus pause, and various degrees of
trioventricular block [2,3,6]. Pilsicainide is largely
xcreted via the kidney and pilsicainide intoxi-
ation has been reported in patients with renal
ysfunction [2,3]. A previous report showed that
ppropriate dosing of pilsicainide in patients on
emodialysis is 25mg before every dialysis and con-
ecutive dose of 25mg/day had induced elevated
lasma concentration [1]. In this case, pilsicainide
ose (50mg/day) might be overdose for a patient
n hemodialysis.
Pilsicainide has negative inotropic effects in a
ose-dependent manner [7]. A single oral dose of
ilsicainide decreases stroke volume index [5], and
ilsicainide intoxication can cause hemodynamic
ollapse without ventricular tachyarrhythmia [3].
here have been no previous reports about hemo-
ynamic proﬁle during pilsicainide intoxication.
his case has demonstrated, for the ﬁrst time,
eft ventricular dyssynchrony during pilsicainide
ntoxication by ventriculography. This dyssynchrony
eemed to be due to intraventricular conduction
elay indicated by marked QRS prolongation on
lectrocardiography. Dyssynchronous left ventric-
lar wall motion depresses global left ventricular
unction [8]. Actually, this patient presented
ith hypotension and right heart catheterization
evealed decreased stroke volume index. After the
ithdrawal of pilsicainide, the hemodynamic pro-
le improved with normalization of left ventricular
unction and narrowing of QRS width.
This patient presented with transient chest
ain and palpitation before admission. Pilsicainide
ntoxication has been known to cause various
rrhythmias [2,3,6], and a case of pilsicainide-
nduced coronary vasospasm has been reported
9]. Although electrocardiogram on admission had
ot showed arrhythmia and ST-segment elevation,
hese mechanisms may account for transient chest
ymptoms of this patient. After cessation of pil-
icainide and hemodialysis, QRS width gradually
arrowed, and blood pressure and pulse rate gradu-
lly stabilized. Thereafter, chest symptoms had not
ecurred.
In this case, Brugada-type electrocardiographic
attern had transiently appeared. Previous reports
[
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ad presented elderly cases of pilsicainide intox-
cation presenting with Brugada-type electrocar-
iographic pattern, caused by renal dysfunc-
ion [2,10]. The relationship between Brugada-
ype electrocardiographic pattern and ventricular
rrhythmia during pilsicainide intoxication is not
lear.
onclusion
e report a case of pilsicainide intoxication pre-
enting with marked QRS prolongation and left
entricular dyssynchrony. We must be cautious
hen we prescribe pilsicainide for a patient on
emodialysis.
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